Beatriz Domínguez

Learn More
1 We thank the audience of the Health Economics Seminar at the Universidad Carlos III for useful comments. All redundancies are due to the second author. All missing explanations are due to the third one. Otherwise, the usual disclaimer applies. 2 BBVA. Abstract It is commonly argued that in recent years pharmaceutical companies have directed their R&D(More)
  • 1